Tonix in the News :: Tonix Pharmaceuticals Holding Corp. (TNXP)

Science | Jul 6, 2017

How Canadian researchers reconstituted an extinct poxvirus for $100,000 using mail-order DNA

The National Post | Mar 2, 2017

Canadian synthesizes a better smallpox vaccine - just in case terrorists bring the disease back

Reuters | May 19, 2016

Tonix Pharma PTSD drug shows promise in mid-stage study

Medscape | Nov 17, 2015

New Approach to Fibromyalgia Tackles Poor-Quality Sleep

PharmaVOICE | Nov 16, 2015

21st Century Cures Act

BioPharma Dive | Oct 8, 2015

An innovation challenge: Using pharma R&D as a tool for social change

Life Science Leader | Jul 1, 2015

Companies to Watch: Tonix Pharmaceuticals

Bioworld Today | May 14, 2015

Lead ‘tonic’ for Tonix targets fibromyalgia in phase III study

Fibromyalgia News Today | May 14, 2015

Tonix Pharmaceuticals Launches Phase 3 Clinical Trial To Evaluate Experimental Fibromyalgia Therapy

The Medicine Maker | May 5, 2015

The Big Leap from Academic to Entrepreneur

Daily News | Nov 11, 2014

Long battles remain for veterans suffering from PTSD

Fibro & Fabulous | Jun 23, 2014

Interview with Dr. Seth Lederman CEO of Tonix Pharmaceuticals

MedCity News | Jun 23, 2014

Tonix Pharmaceuticals developing treatment for underserved PTSD patients

Fierce Pharma | Jun 10, 2014

Tonix receives IND approval for sublingual formulation to treat PTSD

Fierce Pharma | May 13, 2014

Tonix's sublingual formulation for fibromyalgia reaches pivotal trial stage

National Pain Report | Apr 23, 2014

Fibromyalgia Drugs: Successes or Failures?

New York Business Journal | Apr 4, 2014

Seth Lederman's Tonix Pharmaceuticals taking shorter path to drug approval

DDN News | Mar 14, 2014

Seth Lederman: Turning something old into something new (Part 2 of 2)

TheStreet | Feb 14, 2014

Tonix CEO: Investors Seeing Value in Reformulation Strategy

DDN News | Feb 13, 2014

Seth Lederman: Looking to past medications for the future (Part 1 of 2)